- Home
- RGT vs CASI Comparison
RGT vs CASI Comparison
Compare RGT & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGT
- CASI
- Stock Information
- Founded
- RGT 1986
- CASI 1991
- Country
- RGT United States
- CASI China
- Employees
- RGT N/A
- CASI N/A
- Industry
- RGT Trusts Except Educational Religious and Charitable
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- RGT Finance
- CASI Health Care
- Exchange
- RGT Nasdaq
- CASI Nasdaq
- Market Cap
- RGT 67.6M
- CASI 58.8M
- IPO Year
- RGT N/A
- CASI 1996
- Fundamental
- Price
- RGT $11.00
- CASI $2.62
- Analyst Decision
- RGT
- CASI Strong Buy
- Analyst Count
- RGT 0
- CASI 1
- Target Price
- RGT N/A
- CASI $6.00
- AVG Volume (30 Days)
- RGT 22.4K
- CASI 42.2K
- Earning Date
- RGT 01-01-0001
- CASI 11-15-2024
- Dividend Yield
- RGT 1.43%
- CASI N/A
- EPS Growth
- RGT N/A
- CASI N/A
- EPS
- RGT 0.92
- CASI N/A
- Revenue
- RGT N/A
- CASI $22,055,000.00
- Revenue This Year
- RGT N/A
- CASI N/A
- Revenue Next Year
- RGT N/A
- CASI $134.79
- P/E Ratio
- RGT $11.42
- CASI N/A
- Revenue Growth
- RGT N/A
- CASI N/A
- 52 Week Low
- RGT $7.84
- CASI $2.05
- 52 Week High
- RGT $11.08
- CASI $8.19
- Technical
- Relative Strength Index (RSI)
- RGT 50.38
- CASI 38.56
- Support Level
- RGT $10.79
- CASI $2.44
- Resistance Level
- RGT $11.00
- CASI $2.76
- Average True Range (ATR)
- RGT 0.17
- CASI 0.29
- MACD
- RGT 0.05
- CASI 0.03
- Stochastic Oscillator
- RGT 77.42
- CASI 21.18
About RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.